Investors speculate on potential stock split for Eli Lilly due to strong weight loss drug performance.

From Nasdaq: 2024-12-30 04:30:00

In 2024, stock splits are a major trend, with companies like Nvidia and Walmart splitting to make shares more accessible. While splits don’t change a company’s value, they hint at confidence in future growth. Investors are eyeing Eli Lilly for a potential split due to strong performance in weight loss drugs, even though the last split was in 1997.

Lilly’s weight loss drugs, Zepbound and Mounjaro, have led to double-digit revenue growth and increased stock prices. While a stock split hasn’t been announced, the recent pullback in Lilly’s stock price may prompt management to consider one. Investors are watching closely as Lilly’s weight loss drugs continue to show blockbuster potential.

Looking for the next big investment opportunity? Consider “Double Down” stock recommendations for companies like Nvidia, Apple, and Netflix, which have seen massive returns. The Motley Fool is issuing alerts for three new companies with promising growth potential. Don’t miss out on this chance to invest before it’s too late.



Read more at Nasdaq: Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?